For the past couple of years, the field has been experiencing a boom in cannabidiol-related research. What has permeated the scientific consensus stems from efforts undertaken to explain effects of THC, with descriptions of cannabidiol just a by-product of the initial purpose. For example, CBD was thought to have been simply a precursor of THC, mainly due to the structural similarities between the two.
CBD hemp oil is the product derived from the hemp plant, which is high in CBD (cannabidiol) and low in THC (tetrahydrocannabinol). This oil has received a large amount of attention in recent years, due to the growing wave of marijuana legislation and debate in many countries, including the United States. While cannabis and smoking marijuana (which often has a high level of the psychotropic compound THC) is still illegal in many places, as more is being learned about CBD, and its potential effects on health, it is becoming more and more accepted as a legal and safe remedy for a wide variety of health conditions. Since it has a minimal amount of the psychotropic compound THC, use of this oil does not result in a traditional “high”, so its effects are generally considered therapeutic, not mind-altering.
A report from the American Academy of Pediatrics (AAP) published in the journal Pediatrics cautions pregnant women and nursing mothers to avoid marijuana use due to possible adverse developmental effects to their baby. In a study reviewed for the report, short-term exposure to CBD was found to increase the permeability of the placental barrier, potentially placing the fetus at risk from certain substances.
More human studies are needed to fully understand the range of risks and side effects that CBD oil may cause. Studies of CBD oil aren’t common. This is partially because Schedule 1 substances like cannabis are highly regulated, causing some obstacles for researchers. With the legalization of marijuana products, more research is possible, and more answers will come.